Home > Insider Trading > Filing (0000950170-24-119051)

Filing Details

Accession Number:: 0000950170-24-119051
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-10-30 16:35:43
Reporting Period:: 2024-10-28

Accepted Time:: 2024-10-30 16:35:43
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1826457	Monte Rosa Therapeutics Inc.	GLUE	()	DE

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1687880	Versant Venture Capital Vi, L.p.	One Sansome Street, Suite 1650 San Francisco CA 94104	No	No	No	No
1765253	Versant Vantage I, L.p.	One Sansome Street, Suite 1650 San Francisco CA 94104	No	No	No	No
1777651	Versant Vantage I Gp, L.p.	One Sansome Street, Suite 1650 San Francisco CA 94104	No	No	No	No
1777652	Versant Ventures Vi Gp-Gp, Llc	One Sansome Street, Suite 1650 San Francisco CA 94104	No	No	No	No
1777653	Versant Vantage I Gp-Gp, Llc	One Sansome Street, Suite 1650 San Francisco CA 94104	No	No	No	No
1777654	Versant Ventures Vi Gp, L.p.	One Sansome Street, Suite 1650 San Francisco CA 94104	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2024-10-28	89,990	$9.66	2,007,948	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2024-10-28	1,019,867	$0.00	4,079,469	No	4	J	Direct
Common Stock	Acquisiton	2024-10-28	20,397	$0.00	20,397	No	4	J	Indirect	See Footnote
Common Stock	Disposition	2024-10-28	20,397	$0.00	0	No	4	J	Indirect	See Footnote
Common Stock	Acquisiton	2024-10-28	17,595	$0.00	17,595	No	4	J	Indirect	See Footnote
Common Stock	Disposition	2024-10-28	17,595	$0.00	0	No	4	J	Indirect	See Footnote
Common Stock	Disposition	2024-10-28	366,590	$0.00	1,641,358	No	4	J	Indirect	See Footnote
Common Stock	Acquisiton	2024-10-28	5,499	$0.00	5,499	No	4	J	Indirect	See Footnote
Common Stock	Disposition	2024-10-28	5,499	$0.00	0	No	4	J	Indirect	See Footnote
Common Stock	Acquisiton	2024-10-28	5,454	$0.00	5,454	No	4	J	Indirect	See Footnote
Common Stock	Disposition	2024-10-28	5,454	$0.00	0	No	4	J	Indirect	See Footnote
Common Stock	Disposition	2024-10-29	52,305	$9.08	1,589,053	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2024-10-29	15,600	$9.41	1,573,453	No	4	S	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnote
No	4	J	Direct
No	4	J	Indirect	See Footnote
No	4	J	Indirect	See Footnote
No	4	J	Indirect	See Footnote
No	4	J	Indirect	See Footnote
No	4	J	Indirect	See Footnote
No	4	J	Indirect	See Footnote
No	4	J	Indirect	See Footnote
No	4	J	Indirect	See Footnote
No	4	J	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote

Footnotes

The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $9.50 to $10.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.
Shares held by Versant Vantage I, L.P. ("Versant Vantage I"). Versant Vantage I GP, L.P. ("Versant Vantage I GP") is the general partner of Versant Vantage I, and Versant Vantage I GP-GP, LLC ("Versant Vantage I GP-GP") is the general partner of Versant Vantage I GP. Each of Versant Vantage I GP-GP and Versant Vantage I GP may be deemed to share voting, investment and dispositive power over the shares held by Versant Vantage I and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein.
Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Venture Capital VI, L.P. ("Versant VI") to its partners.
Shares held by Versant VI. Versant Ventures VI GP, L.P. ("Versant Ventures VI GP") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC ("Versant Ventures VI GP-GP") is the general partner of Versant Ventures VI GP. Each of Versant Ventures VI GP-GP and Versant Ventures VI GP may be deemed to share voting, investment and dispositive power over the shares held by Versant VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein.
Represents a change in the form of ownership of Versant Ventures VI GP by virtue of the receipt of shares as a result of the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant VI.
Shares held by Versant Ventures VI GP. Versant Ventures VI GP-GP is the general partner of Versant Ventures VI GP and may be deemed to share voting, investment and dispositive power over the shares held by Versant Ventures VI GP and disclaims beneficial ownership of such shares except to the extent of its pecuniary interest therein.
Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Ventures VI GP to its partners.
Represents a change in the form of ownership of Versant Ventures VI GP-GP by virtue of the receipt of shares as a result of the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant Ventures VI GP.
Shares held by Versant Ventures VI GP-GP.
Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Ventures VI GP-GP to its members.
Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Vantage I to its partners.
Represents a change in the form of ownership of Versant Vantage I GP by virtue of the receipt of shares as a result of the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant Vantage I.
Shares held by Versant Vantage I GP. Versant Vantage I GP-GP is the general partner of Versant Vantage I GP and may be deemed to share voting, investment and dispositive power over the shares held by Versant Vantage I GP and disclaims beneficial ownership of such shares except to the extent of its pecuniary interest therein.
Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Vantage I GP to its partners.
Represents a change in the form of ownership of Versant Vantage I GP-GP by virtue of the receipt of shares as a result of the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant Vantage I GP.
Shares held by Versant Vantage I GP-GP.
Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Vantage I GP-GP to its members.
The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $8.36 to $9.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (18) to this Form 4.
The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $9.33 to $9.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (19) to this Form 4.